JP2002535293A5 - - Google Patents

Download PDF

Info

Publication number
JP2002535293A5
JP2002535293A5 JP2000594511A JP2000594511A JP2002535293A5 JP 2002535293 A5 JP2002535293 A5 JP 2002535293A5 JP 2000594511 A JP2000594511 A JP 2000594511A JP 2000594511 A JP2000594511 A JP 2000594511A JP 2002535293 A5 JP2002535293 A5 JP 2002535293A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
skin
particles
placebo
mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535293A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2000/000156 external-priority patent/WO2000043058A1/en
Publication of JP2002535293A publication Critical patent/JP2002535293A/ja
Publication of JP2002535293A5 publication Critical patent/JP2002535293A5/ja
Pending legal-status Critical Current

Links

JP2000594511A 1999-01-22 2000-01-21 無針の経皮的粉末薬物送達を増強する方法 Pending JP2002535293A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11690799P 1999-01-22 1999-01-22
US23594499A 1999-01-22 1999-01-22
US09/235,944 1999-01-22
US60/116,907 1999-01-22
PCT/GB2000/000156 WO2000043058A1 (en) 1999-01-22 2000-01-21 Method of enhancing needleless transdermal powdered drug delivery

Publications (2)

Publication Number Publication Date
JP2002535293A JP2002535293A (ja) 2002-10-22
JP2002535293A5 true JP2002535293A5 (pl) 2007-03-29

Family

ID=26814746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000594511A Pending JP2002535293A (ja) 1999-01-22 2000-01-21 無針の経皮的粉末薬物送達を増強する方法

Country Status (6)

Country Link
EP (1) EP1148902A1 (pl)
JP (1) JP2002535293A (pl)
AU (1) AU765429B2 (pl)
CA (1) CA2358584A1 (pl)
IL (2) IL144380A0 (pl)
WO (1) WO2000043058A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1146861E (pt) 1999-02-03 2005-10-31 Powderject Res Ltd Formulacoes de particulas de hidrogel
US7635488B2 (en) 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
FR2822049B1 (fr) 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
JP2006335754A (ja) * 2005-06-01 2006-12-14 Technofarm Axesz Kk 経皮投与剤担持薄膜とその製造法
FR2921562B1 (fr) * 2007-10-01 2012-06-15 Dbv Tech Dispositif adhesif pour application cutanee
FR2924350B1 (fr) 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
CN103298507B (zh) * 2010-10-07 2015-08-26 麻省理工学院 采用线性洛仑兹力致动的无针射流注射系统递送固体和/或流体
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
EP2979714A1 (de) * 2014-08-02 2016-02-03 LTS LOHMANN Therapie-Systeme AG Nadellose Injektionsvorrichtung aufweisend eine Membran

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233169B1 (pl) * 1971-04-14 1977-08-26
US4831023A (en) * 1986-06-27 1989-05-16 Thames Pharmacal Co., Inc. Water washable vehicles for topical use
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
WO1998029134A2 (en) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
IL120943A (en) * 1997-05-29 2004-03-28 Univ Ben Gurion A system for administering drugs through the skin

Similar Documents

Publication Publication Date Title
Smart Drug delivery using buccal-adhesive systems
AU767373B2 (en) Gum pad for delivery of medication to mucosal tissues
US7306812B2 (en) Dissolvable backing layer for use with a transmucosal delivery device
ES2237104T3 (es) Dispositivo portador de productos farmaceuticos adecuado para el aporte de compuestos farmaceuticos a superficies mucosas.
TWI343263B (en) Patches for mucosa of oral cavity containing fentanyl
ES2270335T7 (es) Composicion farmaceuta de efecto.
US5942242A (en) Medicaments for nasal administration
ES2411179T3 (es) Oblea de buprenorfina para la terapia de sustitución de drogas
JP2009535397A (ja) 経粘膜的組成物
JP2006528975A (ja) 経粘膜送達デバイスとともに使用のための溶解可能な裏打ち層
TW201043280A (en) Pharmaceutical system for trans-membrane delivery
JP2002535293A5 (pl)
Patel et al. Mucoadhesive buccal drug delivery system.
JP2006513184A5 (pl)
DE69730988D1 (de) Neue formulierungen zur transdermale verabreichung von fluoxetinacetat und fluoxetinmaleat
JP2006516571A5 (pl)
JP2007537131A (ja) 抗ウイルス組成物および同一物を使用する方法
AU2006215805B2 (en) Method for a treatment with a medicament combination and medicament combinations suitable for the same
TW201238597A (en) Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same
Sheoran Buccal drug delivery system: A review
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
JP2003514025A5 (pl)
JP2002530353A5 (pl)
JP2002535293A (ja) 無針の経皮的粉末薬物送達を増強する方法
JP2007504268A5 (pl)